Ending Federal Funding for Irreversible Gender Procedures on Children

The Trump administration has moved to end federal funding for hospitals that perform so-called “gender-affirming” medical procedures on minors, fulfilling a key campaign promise to protect children from irreversible harm.

Under new rules issued by the Centers for Medicare and Medicaid Services (CMS), any facility that provides puberty blockers, cross-sex hormones, or sex-reassignment surgeries to minors will lose eligibility to participate in Medicare and Medicaid. The policy also blocks Medicaid’s Children’s Health Insurance Program (CHIP) from funding these procedures for anyone under 19—impacting a program that serves millions of children nationwide.